Treatment Efficacy for Drug Abuse and AIDS Prevention - 2

National Institutes of Health (NIH)

Status and phase: Completed; Phase 2

Conditions: Heroin Dependence; Cocaine-Related Disorders

Treatments: Drug: Buprenorphine

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000211

R18-06116-2

NIDA-06116-2

Details and patient eligibility

About

The purpose of this study is to assess the safety and effectiveness of buprenorphine for treatment of concurrent intravenous heroin and cocaine dependence.

Sex: Male

Ages: 26 to 41 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.